The mode of recognition of tumor antigens by noncytolytic-type antitumor T cells: Role of antigen-presenting cells and their surface class I and class II H-2 molecules

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF00205449PMID 3141057PMCID PMC11038580
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms for Recognition of Tumor Antigens and Mediation of Anti‐tumor Effect by Noncytolytic Lyt‐2+ T Cell Subset

  1988cited by this paper
• Role of tumor-specific Lyt-2[+] T cells in tumor growth inhibition in vivo : mechanisms for recognition of tumor antigens and mediation of anti-tumor effect by noncytolytic Lyt-2[+] T cell subset

  1988influential reference
• Mediation of in vivo Tumor‐neutralizing Activity by Lyt‐2+ as Well as L3T4+ T Cell Subsets

  1988cited by this paper
• The Activation of L3T4+ Helper T Cells Assisting the Generation of Anti‐Tumor Lyt‐2+ Cytotoxic T Lymphocytes: Requirement of 1a‐Positive Antigen‐Presenting Cells for Processing and Presentation of Tumor Antigens

  1987cited by this paper
• Studies on macrophage-activating factor (MAF) in antitumor immune responses

  1987cited by this paper
• Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection

  1987cited by this paper
• Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.

  1986cited by this paper
• Analysis of T-cell subsets in rejection of Kb mutant skin allografts differing at class I MHC

  1986cited by this paper
• Requirements of adherent cells for activating Lyt-1+2- T cells as well as for functioning as antitumor effectors activated by factor(s) from Lyt-1+2- T cells.

  1986cited by this paper
• Both L3T4+ and Lyt-2+ helper T cells initiate cytotoxic T lymphocyte responses against allogenic major histocompatibility antigens but not against trinitrophenyl-modified self

  1985cited by this paper
• Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.

  1985cited by this paper
• Properties of purified T cell subsets. I. In vitro responses to class I vs. class II H-2 alloantigens

  1985cited by this paper
• The mechanism of tumor growth inhibition by tumor-specific Lyt-1+2-T cells. I. Antitumor effect of Lyt-1+2-T cells depends on the existence of adherent cells.

  1985cited by this paper
• Mechanisms of Rejection and Prolongation of Vascularized Organ Allografts

  1984cited by this paper
• The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.

  1984cited by this paper
• T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.

  1984cited by this paper
• A reexamination of the role of LYT-2-positive T cells in murine skin graft rejection

  1984cited by this paper
• Cloning and expression of murine immune interferon cDNA.

  1983cited by this paper
• IMMUNE MECHANISMS IN ORGAN ALLOGRAFT REJECTION: I. DELAYED‐TYPE HYPERSENSITIVITY AND LYMPHOCYTOTOXICITY IN HEART GRAFT REJECTION

  1983cited by this paper
• Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.

  1983cited by this paper
• Characterization of the Murine Antigenic Determinant, Designated L3T4a, Recognized by Monoclonal Antibody GK 1.5: Expression of L3T4a by Functional T Cell Clones Appears to Correlate Primarily with Class II MHC Antigen‐Reactivity

  1983cited by this paper
• Murine syngeneic mixed lymphocyte response. I. Target antigens are self Ia molecules

  1981cited by this paper
• Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection

  1981cited by this paper
• Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes

  1981cited by this paper
• Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes

  1980cited by this paper
• Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.

  1980cited by this paper
• Helper cells activated by allogeneic H-2K or H-2D differences have a Ly phenotype distinct from those responsive to I differences.

  1979cited by this paper
• Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens.

  1978cited by this paper
• Preferential generation of killer or helper T-lymphocyte activity directed to the tumour-associated transplantation antigens.

  1976cited by this paper
• A rapid method for the isolation of functional thymus‐derived murine lymphocytes

  1973cited by this paper

• β-Glucan: A dual regulator of apoptosis and cell proliferation.

  2021cites this paper
• Tumor-immunotherapy with the use of tumor-antigen-pulsed antigen-presenting cells

  2005cites this paper
• Bulk cultures of canine peripheral blood lymphocytes with solid phase anti-CD3 antibody and recombinant interleukin-2 for use in immunotherapy.

  2003cites this paper
• Defect of the CTLA4-Ig ligands on tumor-infiltrating dendritic cells.

  1995cites this paper
• Infiltration of dendritic cells into regional lymph nodes in gastric cancer

  1995cites this paper
• Mechanisms of ultraviolet radiation carcinogenesis.

  1994cites this paper
• In vivo and in vitro reactivity of rat spleen cells against regressor and progressor colon‐cancer cell variants

  1993cites this paper
• HLA Class I and Class II Antigen Expression in Gastric Cancer Cells and Induction of Its Expression by Local Injection of OK-432

  1993cites this paper
• Transforming Growth Factor‐β CD4+ T cells Tumor‐bearing state Immunosuppression Enhanced Production of TGF‐β and a Progressive Increase in TGF‐β Susceptibility of Anti‐tumor CD4+ T Cell Function

  1993cites this paper
• The role of idiotype-specific, CD4+ T cells in tumor resistance against major histocompatibility complex class II molecule negative plasmacytoma cells.

  1993cites this paper
• Tumor‐specific T Cell Lines: Capacity to Proliferate and Produce Interleukin 2 in Response to Various Forms of Tumor Antigens

  1992cites this paper
• Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activity.

  1992cites this paper
• Tumor antigen presentation by murine epidermal cells.

  1991cites this paper
• Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts.

  1991cites this paper
• T cell subsets and IFN-gamma production in resistance to systemic candidosis in immunized mice.

  1990cites this paper
• T‐cell subsets, IFN‐γ production and efferent specificity in anti‐parental tumor immunity induced by mouse sensitization with xenogenized variant cells

  1990cites this paper